(VIANEWS) – Shares of Novo Nordisk A/S (NVO) rose 5.67% to $98.40 at 12:22 EST on Wednesday, following the last session’s upward trend. NYSE Composite is sliding 0.56% to $16,619.14, after two consecutive sessions in a row of losses. This seems, up until now, a somewhat bearish trend exchanging session today.
Novo Nordisk A/S’s last close was $92.60, 0.46% above its 52-week high of $92.18.
Today’s last reported volume for Novo Nordisk A/S is 2233413 which is 142.38% above its average volume of 921434.
Novo Nordisk A/S’s Sales
Novo Nordisk A/S’s sales growth is 8.1% for the ongoing quarter and 7.2% for the next. The company’s growth estimates for the current quarter and the next is 6.9% and 5.6%, respectively.
Novo Nordisk A/S’s Revenue
Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 126.88B for the twelve trailing months.
Novo Nordisk A/S’s last week, last month’s, and last quarter’s current volatility was 0.92%, 0.44%, and 0.86%, respectively.
Novo Nordisk A/S’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.75% (last week), 0.88% (last month), and 0.86% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Novo Nordisk A/S’s stock is considered to be oversold (<=20).
Novo Nordisk A/S’s Stock Yearly Top and Bottom Value
Novo Nordisk A/S’s stock is valued at $98.40 at 12:22 EST, above its 52-week high of $92.18.
Novo Nordisk A/S’s Moving Average
Novo Nordisk A/S’s value is way higher than its 50-day moving average of $85.13 and way higher than its 200-day moving average of $76.14.
More news about Novo Nordisk A/S (NVO).